Abbott Sues Qiagen Over Pact for PCR-Based HPV Detection Methods

The suit seeks to compel Qiagen to arbitrate a dispute related to a licensing deal Abbott had in place with Viropath and Digene, which Qiagen acquired in 2007.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.